Efficacy of nicergoline treatment in Parkinson’s disease associated with dementia

In conclusions, nicergoline appears to delay the speed of deterioration of cognitive function in patients with PDD based on our observation of decreased rCBF in the temporal regions and inferior frontal regions of PDD − N patients compared to PDD + N patients after 12-month of nicergoline therapy. Therefore, we cautiously suggest that nicergoline administration in PDD patients may slow progression of cognitive impairment in affected brain regions.
Source: Journal of Clinical Neuroscience - Category: Neuroscience Source Type: research